speb/financial-data huggingface dataset:
URC.TO balance_sheet (quarterly, 2025-10-31) — Invested Capital: 330427000.00
URC.TO cash_flow (quarterly, 2025-10-31) — Investing Cash Flow: 36879000.00
URC.TO balance_sheet (quarterly, 2025-10-31) — Long Term Capital Lease Obligation: 125000.00
URC.TO balance_sheet (quarterly, 2025-10-31) — Long Term Debt And Capital Lease Obligation: 125000.00
URC.TO cash_flow (quarterly, 2025-10-31) — Long Term Debt Payments: -17000.00
URC.TO cash_flow (quarterly, 2025-10-31) — Net Foreign Currency Exchange Gain Loss: -629000.00
URC.TO income_statement (quarterly, 2025-10-31) — Net Income: 2055000.00
URC.TO income_statement (quarterly, 2025-10-31) — Net Income Common Stockholders: 2055000.00
URC.TO income_statement (quarterly, 2025-10-31) — Net Income Continuous Operations: 2055000.00
URC.TO income_statement (quarterly, 2025-10-31) — Net Income From Continuing And Discontinued Operation: 2055000.00
URC.TO income_statement (quarterly, 2025-10-31) — Net Income From Continuing Operation Net Minority Interest: 2055000.00
URC.TO cash_flow (quarterly, 2025-10-31) — Net Income From Continuing Operations: 1756000.00
URC.TO income_statement (quarterly, 2025-10-31) — Net Income Including Noncontrolling Interests: 2055000.00
URC.TO income_statement (quarterly, 2025-10-31) — Net Interest Income: 286000.00
URC.TO cash_flow (quarterly, 2025-10-31) — Net Investment Purchase And Sale: 36588000.00
URC.TO cash_flow (quarterly, 2025-10-31) — Net Issuance Payments Of Debt: -17000.00
URC.TO cash_flow (quarterly, 2025-10-31) — Net Long Term Debt Issuance: -17000.00
URC.TO income_statement (quarterly, 2025-10-31) — Net Non Operating Interest Income Expense: 286000.00
URC.TO balance_sheet (quarterly, 2025-10-31) — Net PPE: 58926000.00
URC.TO cash_flow (quarterly, 2025-10-31) — Net PPE Purchase And Sale: 0.00
URC.TO balance_sheet (quarterly, 2025-10-31) — Net Tangible Assets: 330427000.00
URC.TO income_statement (quarterly, 2025-10-31) — Normalized EBITDA: -2890000.00
URC.TO income_statement (quarterly, 2025-10-31) — Normalized Income: -1935750.00
URC.TO cash_flow (quarterly, 2025-10-31) — Operating Cash Flow: -2727000.00
URC.TO cash_flow (quarterly, 2025-10-31) — Operating Gains Losses: -4695000.00
URC.TO income_statement (quarterly, 2025-10-31) — Operating Income: -3224000.00
URC.TO income_statement (quarterly, 2025-10-31) — Operating Revenue: 41000.00
URC.TO balance_sheet (quarterly, 2025-10-31) — Ordinary Shares Number: 138352709.00
URC.TO balance_sheet (quarterly, 2025-10-31) — Other Equity Adjustments: 6563000.00
URC.TO income_statement (quarterly, 2025-10-31) — Other Gand A: 2210000.00
URC.TO income_statement (quarterly, 2025-10-31) — Other Income Expense: 4695000.00
URC.TO cash_flow (quarterly, 2025-10-31) — Other Non Cash Items: -287000.00
URC.TO income_statement (quarterly, 2025-10-31) — Other Operating Expenses: 288000.00
URC.TO balance_sheet (quarterly, 2025-10-31) — Other Properties: 161000.00
URC.TO balance_sheet (quarterly, 2025-10-31) — Other Receivables: 254000.00
URC.TO balance_sheet (quarterly, 2025-10-31) — Other Short Term Investments: 9793000.00
URC.TO balance_sheet (quarterly, 2025-10-31) — Payables: 968000.00
URC.TO balance_sheet (quarterly, 2025-10-31) — Payables And Accrued Expenses: 968000.00
URC.TO income_statement (quarterly, 2025-10-31) — Pretax Income: 1757000.00
URC.TO cash_flow (quarterly, 2025-10-31) — Proceeds From Stock Option Exercised: 662000.00
URC.TO cash_flow (quarterly, 2025-10-31) — Purchase Of Investment: 0.00
URC.TO cash_flow (quarterly, 2025-10-31) — Purchase Of PPE: 0.00
URC.TO balance_sheet (quarterly, 2025-10-31) — Receivables: 317000.00
URC.TO income_statement (quarterly, 2025-10-31) — Reconciled Cost Of Revenue: 29000.00
URC.TO income_statement (quarterly, 2025-10-31) — Reconciled Depreciation: 44000.00
URC.TO cash_flow (quarterly, 2025-10-31) — Repayment Of Debt: -17000.00
URC.TO balance_sheet (quarterly, 2025-10-31) — Restricted Cash: 110000.00
URC.TO balance_sheet (quarterly, 2025-10-31) — Retained Earnings: 20805000.00
URC.TO income_statement (quarterly, 2025-10-31) — Salaries And Wages: 738000.00
URC.TO income_statement (quarterly, 2025-10-31) — Selling General And Administration: 2948000.00
URC.TO balance_sheet (quarterly, 2025-10-31) — Share Issued: 138352709.00
URC.TO cash_flow (quarterly, 2025-10-31) — Stock Based Compensation: 445000.00
URC.TO balance_sheet (quarterly, 2025-10-31) — Stockholders Equity: 330427000.00
URC.TO balance_sheet (quarterly, 2025-10-31) — Tangible Book Value: 330427000.00
URC.TO income_statement (quarterly, 2025-10-31) — Tax Effect Of Unusual Items: 704250.00
URC.TO income_statement (quarterly, 2025-10-31) — Tax Provision: -298000.00
URC.TO income_statement (quarterly, 2025-10-31) — Tax Rate For Calcs: 0.15
URC.TO balance_sheet (quarterly, 2025-10-31) — Total Assets: 331578000.00
URC.TO balance_sheet (quarterly, 2025-10-31) — Total Capitalization: 330427000.00
URC.TO balance_sheet (quarterly, 2025-10-31) — Total Debt: 183000.00
URC.TO balance_sheet (quarterly, 2025-10-31) — Total Equity Gross Minority Interest: 330427000.00
URC.TO income_statement (quarterly, 2025-10-31) — Total Expenses: 3265000.00
URC.TO balance_sheet (quarterly, 2025-10-31) — Total Liabilities Net Minority Interest: 1151000.00
URC.TO balance_sheet (quarterly, 2025-10-31) — Total Non Current Assets: 58926000.00
URC.TO balance_sheet (quarterly, 2025-10-31) — Total Non Current Liabilities Net Minority Interest: 125000.00
URC.TO income_statement (quarterly, 2025-10-31) — Total Operating Income As Reported: -3224000.00
URC.TO income_statement (quarterly, 2025-10-31) — Total Unusual Items: 4695000.00
URC.TO income_statement (quarterly, 2025-10-31) — Total Unusual Items Excluding Goodwill: 4695000.00
URC.TO balance_sheet (quarterly, 2025-10-31) — Working Capital: 271626000.00
URC.TO income_statement (quarterly, 2026-01-31) — +Operating Expense: 1835000.00
URC.TO income_statement (quarterly, 2026-01-31) — +Total Revenue: 16660000.00
URC.TO balance_sheet (quarterly, 2026-01-31) — Accounts Payable: 938000.00
URC.TO balance_sheet (quarterly, 2026-01-31) — Accounts Receivable: 8000.00
URC.TO balance_sheet (quarterly, 2026-01-31) — Accumulated Depreciation: -1763000.00
URC.TO income_statement (quarterly, 2026-01-31) — Basic Average Shares: 141381411.00
URC.TO income_statement (quarterly, 2026-01-31) — Basic EPS: 0.01
URC.TO cash_flow (quarterly, 2026-01-31) — Beginning Cash Position: 72533000.00
URC.TO balance_sheet (quarterly, 2026-01-31) — Capital Lease Obligations: 168000.00
URC.TO balance_sheet (quarterly, 2026-01-31) — Capital Stock: 347951000.00
URC.TO balance_sheet (quarterly, 2026-01-31) — Cash And Cash Equivalents: 124171000.00
URC.TO balance_sheet (quarterly, 2026-01-31) — Cash Cash Equivalents And Short Term Investments: 138773000.00
URC.TO balance_sheet (quarterly, 2026-01-31) — Cash Financial: 124171000.00
URC.TO cash_flow (quarterly, 2026-01-31) — Cash Flow From Continuing Financing Activities: 44823000.00
URC.TO cash_flow (quarterly, 2026-01-31) — Cash Flow From Continuing Investing Activities: 643000.00
URC.TO cash_flow (quarterly, 2026-01-31) — Cash Flow From Continuing Operating Activities: 8132000.00
URC.TO cash_flow (quarterly, 2026-01-31) — Change In Account Payable: -30000.00
URC.TO cash_flow (quarterly, 2026-01-31) — Change In Inventory: 5130000.00
URC.TO cash_flow (quarterly, 2026-01-31) — Change In Payables And Accrued Expense: -30000.00
URC.TO cash_flow (quarterly, 2026-01-31) — Change In Prepaid Assets: -260000.00
URC.TO cash_flow (quarterly, 2026-01-31) — Change In Receivables: 55000.00
URC.TO cash_flow (quarterly, 2026-01-31) — Change In Working Capital: 4895000.00
URC.TO cash_flow (quarterly, 2026-01-31) — Changes In Account Receivables: 55000.00
URC.TO cash_flow (quarterly, 2026-01-31) — Changes In Cash: 53598000.00
URC.TO balance_sheet (quarterly, 2026-01-31) — Common Stock: 347951000.00
URC.TO balance_sheet (quarterly, 2026-01-31) — Common Stock Equity: 381026000.00
URC.TO cash_flow (quarterly, 2026-01-31) — Common Stock Issuance: 44838000.00
URC.TO income_statement (quarterly, 2026-01-31) — Cost Of Revenue: 11897000.00
URC.TO balance_sheet (quarterly, 2026-01-31) — Current Assets: 324304000.00
URC.TO balance_sheet (quarterly, 2026-01-31) — Current Capital Lease Obligation: 59000.00
URC.TO balance_sheet (quarterly, 2026-01-31) — Current Debt And Capital Lease Obligation: 59000.00
URC.TO balance_sheet (quarterly, 2026-01-31) — Current Liabilities: 997000.00
URC.TO cash_flow (quarterly, 2026-01-31) — Depletion: 28000.00
URC.TO cash_flow (quarterly, 2026-01-31) — Depreciation: 13000.00
URC.TO cash_flow (quarterly, 2026-01-31) — Depreciation Amortization Depletion: 41000.00
URC.TO cash_flow (quarterly, 2026-01-31) — Depreciation And Amortization: 13000.00
URC.TO income_statement (quarterly, 2026-01-31) — Diluted Average Shares: 142082502.00
URC.TO income_statement (quarterly, 2026-01-31) — Diluted EPS: 0.01
URC.TO income_statement (quarterly, 2026-01-31) — Diluted NI Availto Com Stockholders: 1962000.00
URC.TO income_statement (quarterly, 2026-01-31) — EBIT: 1611000.00
URC.TO income_statement (quarterly, 2026-01-31) — EBITDA: 1652000.00
URC.TO cash_flow (quarterly, 2026-01-31) — Effect Of Exchange Rate Changes: -1960000.00
URC.TO cash_flow (quarterly, 2026-01-31) — End Cash Position: 124171000.00
URC.TO cash_flow (quarterly, 2026-01-31) — Financing Cash Flow: 44823000.00
URC.TO cash_flow (quarterly, 2026-01-31) — Free Cash Flow: 8132000.00
URC.TO cash_flow (quarterly, 2026-01-31) — Gain Loss On Investment Securities: 0.00
URC.TO income_statement (quarterly, 2026-01-31) — Gain On Sale Of Security: -1960000.00
URC.TO balance_sheet (quarterly, 2026-01-31) — Gains Losses Not Affecting Retained Earnings: 10308000.00
URC.TO income_statement (quarterly, 2026-01-31) — General And Administrative Expense: 1802000.00
URC.TO balance_sheet (quarterly, 2026-01-31) — Gross PPE: 59885000.00
URC.TO income_statement (quarterly, 2026-01-31) — Gross Profit: 4763000.00
URC.TO income_statement (quarterly, 2026-01-31) — Interest Expense: 4000.00
URC.TO income_statement (quarterly, 2026-01-31) — Interest Expense Non Operating: 4000.00
URC.TO income_statement (quarterly, 2026-01-31) — Interest Income: 643000.00
URC.TO income_statement (quarterly, 2026-01-31) — Interest Income Non Operating: 643000.00
URC.TO cash_flow (quarterly, 2026-01-31) — Interest Received Cfi: 643000.00
URC.TO balance_sheet (quarterly, 2026-01-31) — Inventory: 184901000.00
URC.TO balance_sheet (quarterly, 2026-01-31) — Invested Capital: 381026000.00
URC.TO cash_flow (quarterly, 2026-01-31) — Investing Cash Flow: 643000.00
URC.TO cash_flow (quarterly, 2026-01-31) — Issuance Of Capital Stock: 44838000.00
URC.TO balance_sheet (quarterly, 2026-01-31) — Long Term Capital Lease Obligation: 109000.00
URC.TO balance_sheet (quarterly, 2026-01-31) — Long Term Debt And Capital Lease Obligation: 109000.00
URC.TO cash_flow (quarterly, 2026-01-31) — Long Term Debt Payments: -17000.00
URC.TO cash_flow (quarterly, 2026-01-31) — Net Common Stock Issuance: 44838000.00
URC.TO cash_flow (quarterly, 2026-01-31) — Net Foreign Currency Exchange Gain Loss: 1960000.00
URC.TO income_statement (quarterly, 2026-01-31) — Net Income: 1962000.00
URC.TO income_statement (quarterly, 2026-01-31) — Net Income Common Stockholders: 1962000.00
URC.TO income_statement (quarterly, 2026-01-31) — Net Income Continuous Operations: 1962000.00
URC.TO income_statement (quarterly, 2026-01-31) — Net Income From Continuing And Discontinued Operation: 1962000.00
URC.TO income_statement (quarterly, 2026-01-31) — Net Income From Continuing Operation Net Minority Interest: 1962000.00
URC.TO cash_flow (quarterly, 2026-01-31) — Net Income From Continuing Operations: 1607000.00
URC.TO income_statement (quarterly, 2026-01-31) — Net Income Including Noncontrolling Interests: 1962000.00
URC.TO income_statement (quarterly, 2026-01-31) — Net Interest Income: 639000.00
URC.TO cash_flow (quarterly, 2026-01-31) — Net Investment Purchase And Sale: 0.00
URC.TO cash_flow (quarterly, 2026-01-31) — Net Issuance Payments Of Debt: -17000.00
URC.TO cash_flow (quarterly, 2026-01-31) — Net Long Term Debt Issuance: -17000.00
URC.TO income_statement (quarterly, 2026-01-31) — Net Non Operating Interest Income Expense: 639000.00
URC.TO balance_sheet (quarterly, 2026-01-31) — Net PPE: 58122000.00
URC.TO cash_flow (quarterly, 2026-01-31) — Net PPE Purchase And Sale: 0.00
URC.TO balance_sheet (quarterly, 2026-01-31) — Net Tangible Assets: 381026000.00
URC.TO balance_sheet (quarterly, 2026-01-31) — Non Current Deferred Liabilities: 294000.00
URC.TO balance_sheet (quarterly, 2026-01-31) — Non Current Deferred Taxes Liabilities: 294000.00
URC.TO income_statement (quarterly, 2026-01-31) — Normalized EBITDA: 3612000.00
URC.TO income_statement (quarterly, 2026-01-31) — Normalized Income: 3138000.00
URC.TO cash_flow (quarterly, 2026-01-31) — Operating Cash Flow: 8132000.00
URC.TO cash_flow (quarterly, 2026-01-31) — Operating Gains Losses: 1960000.00
URC.TO income_statement (quarterly, 2026-01-31) — Operating Income: 2928000.00
URC.TO income_statement (quarterly, 2026-01-31) — Operating Revenue: 16660000.00
URC.TO balance_sheet (quarterly, 2026-01-31) — Ordinary Shares Number: 146477507.00
URC.TO balance_sheet (quarterly, 2026-01-31) — Other Equity Adjustments: 10308000.00
URC.TO income_statement (quarterly, 2026-01-31) — Other Gand A: 1234000.00
URC.TO income_statement (quarterly, 2026-01-31) — Other Income Expense: -1960000.00
URC.TO cash_flow (quarterly, 2026-01-31) — Other Non Cash Items: -639000.00
URC.TO income_statement (quarterly, 2026-01-31) — Other Operating Expenses: 33000.00
URC.TO balance_sheet (quarterly, 2026-01-31) — Other Properties: 148000.00
URC.TO balance_sheet (quarterly, 2026-01-31) — Other Receivables: 512000.00
URC.TO balance_sheet (quarterly, 2026-01-31) — Other Short Term Investments: 14602000.00
URC.TO balance_sheet (quarterly, 2026-01-31) — Payables: 938000.00
URC.TO balance_sheet (quarterly, 2026-01-31) — Payables And Accrued Expenses: 938000.00
URC.TO income_statement (quarterly, 2026-01-31) — Pretax Income: 1607000.00
URC.TO cash_flow (quarterly, 2026-01-31) — Proceeds From Stock Option Exercised: 2000.00
URC.TO cash_flow (quarterly, 2026-01-31) — Purchase Of Investment: 0.00
URC.TO cash_flow (quarterly, 2026-01-31) — Purchase Of PPE: 0.00
URC.TO balance_sheet (quarterly, 2026-01-31) — Receivables: 520000.00
URC.TO income_statement (quarterly, 2026-01-31) — Reconciled Cost Of Revenue: 11897000.00
URC.TO income_statement (quarterly, 2026-01-31) — Reconciled Depreciation: 41000.00
URC.TO cash_flow (quarterly, 2026-01-31) — Repayment Of Debt: -17000.00
URC.TO balance_sheet (quarterly, 2026-01-31) — Restricted Cash: 110000.00
URC.TO balance_sheet (quarterly, 2026-01-31) — Retained Earnings: 22767000.00
URC.TO income_statement (quarterly, 2026-01-31) — Salaries And Wages: 568000.00
URC.TO cash_flow (quarterly, 2026-01-31) — Sale Of Investment: 0.00
URC.TO income_statement (quarterly, 2026-01-31) — Selling General And Administration: 1802000.00
URC.TO balance_sheet (quarterly, 2026-01-31) — Share Issued: 146477507.00
URC.TO cash_flow (quarterly, 2026-01-31) — Stock Based Compensation: 268000.00
URC.TO balance_sheet (quarterly, 2026-01-31) — Stockholders Equity: 381026000.00
URC.TO balance_sheet (quarterly, 2026-01-31) — Tangible Book Value: 381026000.00
URC.TO income_statement (quarterly, 2026-01-31) — Tax Effect Of Unusual Items: -784000.00
URC.TO income_statement (quarterly, 2026-01-31) — Tax Provision: -355000.00
URC.TO income_statement (quarterly, 2026-01-31) — Tax Rate For Calcs: 0.40
URC.TO balance_sheet (quarterly, 2026-01-31) — Total Assets: 382426000.00
URC.TO balance_sheet (quarterly, 2026-01-31) — Total Capitalization: 381026000.00
URC.TO balance_sheet (quarterly, 2026-01-31) — Total Debt: 168000.00
URC.TO balance_sheet (quarterly, 2026-01-31) — Total Equity Gross Minority Interest: 381026000.00
URC.TO income_statement (quarterly, 2026-01-31) — Total Expenses: 13732000.00
URC.TO balance_sheet (quarterly, 2026-01-31) — Total Liabilities Net Minority Interest: 1400000.00
URC.TO balance_sheet (quarterly, 2026-01-31) — Total Non Current Assets: 58122000.00
URC.TO balance_sheet (quarterly, 2026-01-31) — Total Non Current Liabilities Net Minority Interest: 403000.00
URC.TO income_statement (quarterly, 2026-01-31) — Total Operating Income As Reported: 2928000.00
URC.TO income_statement (quarterly, 2026-01-31) — Total Unusual Items: -1960000.00
URC.TO income_statement (quarterly, 2026-01-31) — Total Unusual Items Excluding Goodwill: -1960000.00
URC.TO balance_sheet (quarterly, 2026-01-31) — Working Capital: 323307000.00
URE.TO cash_flow (annual, 2021-12-31) — Asset Impairment Charge: 0.00
URE.TO balance_sheet (annual, 2021-12-31) — Assets Held For Sale Current: 1536000.00
URE.TO balance_sheet (annual, 2021-12-31) — Current Debt: 1262000.00
URE.TO income_statement (annual, 2021-12-31) — Interest Expense: 733000.00
URE.TO income_statement (annual, 2021-12-31) — Interest Expense Non Operating: 733000.00
URE.TO cash_flow (annual, 2021-12-31) — Issuance Of Debt: 0.00
URE.TO balance_sheet (annual, 2021-12-31) — Long Term Debt: 11060000.00
URE.TO cash_flow (annual, 2021-12-31) — Long Term Debt Issuance: 0.00
URE.TO balance_sheet (annual, 2021-12-31) — Other Current Borrowings: 1262000.00
URE.TO balance_sheet (annual, 2021-12-31) — Other Current Liabilities: 2027000.00
URE.TO balance_sheet (annual, 2021-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 83000.00
URE.TO cash_flow (annual, 2021-12-31) — Provisionand Write Offof Assets: -5000.00
URE.TO cash_flow (annual, 2021-12-31) — Sale Of PPE: 0.00
URE.TO income_statement (annual, 2022-12-31) — +Operating Expense: 12952000.00
URE.TO income_statement (annual, 2022-12-31) — +Total Revenue: 19000.00
URE.TO balance_sheet (annual, 2022-12-31) — Accounts Payable: 660000.00
URE.TO balance_sheet (annual, 2022-12-31) — Accounts Receivable: 8000.00
URE.TO balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -20804000.00
URE.TO balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 19843000.00
URE.TO balance_sheet (annual, 2022-12-31) — Assets Held For Sale Current: 0.00
URE.TO income_statement (annual, 2022-12-31) — Basic Average Shares: 220496862.00
URE.TO income_statement (annual, 2022-12-31) — Basic EPS: -0.08
URE.TO cash_flow (annual, 2022-12-31) — Beginning Cash Position: 54155000.00
URE.TO cash_flow (annual, 2022-12-31) — Capital Expenditure: -709000.00
URE.TO balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 16000.00
URE.TO balance_sheet (annual, 2022-12-31) — Capital Stock: 258646000.00
URE.TO balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 33003000.00
URE.TO balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 33003000.00
URE.TO balance_sheet (annual, 2022-12-31) — Cash Equivalents: 30443000.00
URE.TO balance_sheet (annual, 2022-12-31) — Cash Financial: 2560000.00
URE.TO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 5893000.00
URE.TO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -709000.00
URE.TO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -18091000.00
URE.TO cash_flow (annual, 2022-12-31) — Change In Inventory: -8841000.00
URE.TO cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: -1696000.00
URE.TO cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -140000.00
URE.TO cash_flow (annual, 2022-12-31) — Change In Receivables: 0.00
URE.TO cash_flow (annual, 2022-12-31) — Change In Working Capital: -10677000.00
URE.TO cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -4000.00
URE.TO cash_flow (annual, 2022-12-31) — Changes In Cash: -12907000.00
URE.TO balance_sheet (annual, 2022-12-31) — Common Stock: 258646000.00
URE.TO balance_sheet (annual, 2022-12-31) — Common Stock Equity: 62499000.00
URE.TO cash_flow (annual, 2022-12-31) — Common Stock Issuance: 3775000.00
URE.TO income_statement (annual, 2022-12-31) — Cost Of Revenue: 6861000.00
URE.TO balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 449000.00
URE.TO balance_sheet (annual, 2022-12-31) — Current Assets: 43944000.00
URE.TO balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 0.00
URE.TO balance_sheet (annual, 2022-12-31) — Current Debt: 5366000.00
URE.TO balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 5366000.00
URE.TO balance_sheet (annual, 2022-12-31) — Current Liabilities: 6603000.00
URE.TO balance_sheet (annual, 2022-12-31) — Current Provisions: 69000.00
URE.TO cash_flow (annual, 2022-12-31) — Depreciation: 3015000.00
URE.TO cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 3015000.00
URE.TO cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 3015000.00
URE.TO balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 2382000.00
URE.TO income_statement (annual, 2022-12-31) — Diluted Average Shares: 220496862.00
URE.TO income_statement (annual, 2022-12-31) — Diluted EPS: -0.08
URE.TO income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -17140000.00
URE.TO income_statement (annual, 2022-12-31) — EBIT: -16677000.00
URE.TO income_statement (annual, 2022-12-31) — EBITDA: -13662000.00
URE.TO cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -108000.00
URE.TO cash_flow (annual, 2022-12-31) — End Cash Position: 41140000.00
URE.TO cash_flow (annual, 2022-12-31) — Financing Cash Flow: 5893000.00
URE.TO cash_flow (annual, 2022-12-31) — Free Cash Flow: -18800000.00
URE.TO cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: -1835000.00
URE.TO income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 1862000.00
URE.TO balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: 4265000.00
URE.TO income_statement (annual, 2022-12-31) — General And Administrative Expense: 6037000.00
URE.TO balance_sheet (annual, 2022-12-31) — Gross PPE: 76618000.00
URE.TO income_statement (annual, 2022-12-31) — Gross Profit: -6842000.00
URE.TO income_statement (annual, 2022-12-31) — Interest Expense: 463000.00
URE.TO income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 463000.00
URE.TO balance_sheet (annual, 2022-12-31) — Inventory: 9903000.00
URE.TO balance_sheet (annual, 2022-12-31) — Invested Capital: 73559000.00
URE.TO cash_flow (annual, 2022-12-31) — Investing Cash Flow: -709000.00
URE.TO cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 3775000.00
URE.TO cash_flow (annual, 2022-12-31) — Issuance Of Debt: 0.00
URE.TO balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 16000.00
URE.TO balance_sheet (annual, 2022-12-31) — Long Term Debt: 5694000.00
URE.TO balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 5710000.00
URE.TO cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 0.00
URE.TO cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -1305000.00
URE.TO balance_sheet (annual, 2022-12-31) — Long Term Provisions: 30701000.00
URE.TO balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 5410000.00
URE.TO cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 3775000.00
URE.TO cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: -25000.00
URE.TO income_statement (annual, 2022-12-31) — Net Income: -17140000.00
URE.TO income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -17140000.00
URE.TO income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -17140000.00
URE.TO income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -17140000.00
URE.TO income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -17140000.00
URE.TO cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -17140000.00
URE.TO income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -17140000.00
URE.TO income_statement (annual, 2022-12-31) — Net Interest Income: -463000.00
URE.TO cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -1305000.00
URE.TO cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -1305000.00
URE.TO income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -463000.00
URE.TO cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -94000.00
URE.TO balance_sheet (annual, 2022-12-31) — Net PPE: 55814000.00
URE.TO cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -709000.00
URE.TO balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 62499000.00
URE.TO income_statement (annual, 2022-12-31) — Normalized EBITDA: -15524000.00
URE.TO income_statement (annual, 2022-12-31) — Normalized Income: -19002000.00
URE.TO cash_flow (annual, 2022-12-31) — Operating Cash Flow: -18091000.00
URE.TO cash_flow (annual, 2022-12-31) — Operating Gains Losses: -1793000.00
URE.TO income_statement (annual, 2022-12-31) — Operating Income: -19794000.00
URE.TO income_statement (annual, 2022-12-31) — Operating Revenue: 0.00
URE.TO balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 224699621.00
URE.TO balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 5366000.00
URE.TO balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: 4265000.00
URE.TO income_statement (annual, 2022-12-31) — Other Gand A: 6037000.00
URE.TO income_statement (annual, 2022-12-31) — Other Income Expense: 3117000.00
URE.TO balance_sheet (annual, 2022-12-31) — Other Inventories: 9903000.00
URE.TO cash_flow (annual, 2022-12-31) — Other Non Cash Items: 7364000.00
URE.TO balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 8137000.00
URE.TO income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 1255000.00
URE.TO income_statement (annual, 2022-12-31) — Other Operating Expenses: 2229000.00
URE.TO balance_sheet (annual, 2022-12-31) — Other Properties: 71208000.00
URE.TO balance_sheet (annual, 2022-12-31) — Payables: 719000.00
URE.TO balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 1168000.00
URE.TO balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 59000.00
URE.TO balance_sheet (annual, 2022-12-31) — Prepaid Assets: 1038000.00
URE.TO income_statement (annual, 2022-12-31) — Pretax Income: -17140000.00
URE.TO cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 3517000.00
URE.TO cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: -2000.00
URE.TO cash_flow (annual, 2022-12-31) — Purchase Of PPE: -709000.00
URE.TO balance_sheet (annual, 2022-12-31) — Receivables: 0.00
URE.TO income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 6861000.00
URE.TO income_statement (annual, 2022-12-31) — Reconciled Depreciation: 3015000.00
URE.TO cash_flow (annual, 2022-12-31) — Repayment Of Debt: -1305000.00
URE.TO income_statement (annual, 2022-12-31) — Research And Development: 4686000.00
URE.TO balance_sheet (annual, 2022-12-31) — Retained Earnings: -220255000.00
URE.TO cash_flow (annual, 2022-12-31) — Sale Of PPE: 0.00
URE.TO income_statement (annual, 2022-12-31) — Selling General And Administration: 6037000.00
URE.TO balance_sheet (annual, 2022-12-31) — Share Issued: 224699621.00
URE.TO cash_flow (annual, 2022-12-31) — Stock Based Compensation: 1142000.00
URE.TO balance_sheet (annual, 2022-12-31) — Stockholders Equity: 62499000.00
URE.TO balance_sheet (annual, 2022-12-31) — Tangible Book Value: 62499000.00
URE.TO income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
URE.TO income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
URE.TO balance_sheet (annual, 2022-12-31) — Total Assets: 107895000.00
URE.TO balance_sheet (annual, 2022-12-31) — Total Capitalization: 68193000.00
URE.TO balance_sheet (annual, 2022-12-31) — Total Debt: 11076000.00
URE.TO balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 62499000.00
URE.TO income_statement (annual, 2022-12-31) — Total Expenses: 19813000.00
URE.TO balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 45396000.00
URE.TO balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 63951000.00
URE.TO balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 38793000.00
URE.TO income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -19794000.00
URE.TO balance_sheet (annual, 2022-12-31) — Total Tax Payable: 59000.00
URE.TO income_statement (annual, 2022-12-31) — Total Unusual Items: 1862000.00
URE.TO income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 1862000.00
URE.TO balance_sheet (annual, 2022-12-31) — Working Capital: 37341000.00
URE.TO income_statement (annual, 2023-12-31) — +Operating Expense: 29156000.00
URE.TO income_statement (annual, 2023-12-31) — +Total Revenue: 17679000.00
URE.TO balance_sheet (annual, 2023-12-31) — Accounts Payable: 1680000.00
URE.TO balance_sheet (annual, 2023-12-31) — Accounts Receivable: 0.00
URE.TO balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -22865000.00
URE.TO balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 19881000.00
URE.TO income_statement (annual, 2023-12-31) — Basic Average Shares: 260044403.00
URE.TO income_statement (annual, 2023-12-31) — Basic EPS: -0.12
URE.TO cash_flow (annual, 2023-12-31) — Beginning Cash Position: 41140000.00
URE.TO cash_flow (annual, 2023-12-31) — Capital Expenditure: -2039000.00
URE.TO balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 849000.00
URE.TO balance_sheet (annual, 2023-12-31) — Capital Stock: 302182000.00
URE.TO balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 59700000.00
URE.TO balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 59700000.00
URE.TO balance_sheet (annual, 2023-12-31) — Cash Equivalents: 48185000.00
URE.TO balance_sheet (annual, 2023-12-31) — Cash Financial: 11515000.00
URE.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 46085000.00
URE.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -2039000.00
URE.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -16982000.00
URE.TO cash_flow (annual, 2023-12-31) — Change In Inventory: -3357000.00
URE.TO cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 991000.00
URE.TO cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -178000.00
URE.TO cash_flow (annual, 2023-12-31) — Change In Receivables: -285000.00
URE.TO cash_flow (annual, 2023-12-31) — Change In Working Capital: -2829000.00
URE.TO cash_flow (annual, 2023-12-31) — Changes In Account Receivables: 0.00
URE.TO cash_flow (annual, 2023-12-31) — Changes In Cash: 27064000.00
URE.TO balance_sheet (annual, 2023-12-31) — Common Stock: 302182000.00
URE.TO balance_sheet (annual, 2023-12-31) — Common Stock Equity: 74870000.00
URE.TO cash_flow (annual, 2023-12-31) — Common Stock Issuance: 53142000.00
URE.TO income_statement (annual, 2023-12-31) — Cost Of Revenue: 19365000.00
URE.TO balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 578000.00
URE.TO balance_sheet (annual, 2023-12-31) — Current Assets: 63669000.00
URE.TO balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 162000.00
URE.TO balance_sheet (annual, 2023-12-31) — Current Debt: 5694000.00
URE.TO balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 5856000.00
URE.TO balance_sheet (annual, 2023-12-31) — Current Liabilities: 10034000.00
URE.TO balance_sheet (annual, 2023-12-31) — Current Provisions: 69000.00
URE.TO cash_flow (annual, 2023-12-31) — Depreciation: 2981000.00
URE.TO cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 2981000.00
URE.TO cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 2981000.00
URE.TO balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 11549000.00
URE.TO income_statement (annual, 2023-12-31) — Diluted Average Shares: 260044403.00
URE.TO income_statement (annual, 2023-12-31) — Diluted EPS: -0.12
URE.TO income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -30656000.00
URE.TO income_statement (annual, 2023-12-31) — EBIT: -30842000.00
URE.TO income_statement (annual, 2023-12-31) — EBITDA: -27861000.00
URE.TO cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 45000.00
URE.TO cash_flow (annual, 2023-12-31) — End Cash Position: 68249000.00
URE.TO cash_flow (annual, 2023-12-31) — Financing Cash Flow: 46085000.00
URE.TO cash_flow (annual, 2023-12-31) — Free Cash Flow: -19021000.00
URE.TO cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 1586000.00
URE.TO income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -1261000.00
URE.TO balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: 3718000.00
URE.TO income_statement (annual, 2023-12-31) — General And Administrative Expense: 6154000.00
URE.TO balance_sheet (annual, 2023-12-31) — Gross PPE: 78815000.00
URE.TO income_statement (annual, 2023-12-31) — Gross Profit: -1686000.00
URE.TO income_statement (annual, 2023-12-31) — Interest Income: 1471000.00
URE.TO income_statement (annual, 2023-12-31) — Interest Income Non Operating: 1471000.00
URE.TO balance_sheet (annual, 2023-12-31) — Inventory: 2571000.00
URE.TO balance_sheet (annual, 2023-12-31) — Invested Capital: 80564000.00
URE.TO cash_flow (annual, 2023-12-31) — Investing Cash Flow: -2039000.00
URE.TO cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 53142000.00
URE.TO balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 687000.00
URE.TO balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 687000.00
URE.TO cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -5409000.00
URE.TO balance_sheet (annual, 2023-12-31) — Long Term Provisions: 31236000.00
URE.TO balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 7507000.00
URE.TO cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 53142000.00
URE.TO cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: -319000.00
URE.TO income_statement (annual, 2023-12-31) — Net Income: -30656000.00
URE.TO income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -30656000.00
URE.TO income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -30656000.00
URE.TO income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -30656000.00
URE.TO income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -30656000.00
URE.TO cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -30656000.00
URE.TO income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -30656000.00
URE.TO income_statement (annual, 2023-12-31) — Net Interest Income: 1471000.00
URE.TO cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -5409000.00
URE.TO cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -5409000.00
URE.TO income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 1471000.00
URE.TO cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -3165000.00
URE.TO balance_sheet (annual, 2023-12-31) — Net PPE: 55950000.00
URE.TO cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -2039000.00
URE.TO balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 74870000.00
URE.TO balance_sheet (annual, 2023-12-31) — Non Current Accounts Receivable: 208000.00
URE.TO income_statement (annual, 2023-12-31) — Normalized EBITDA: -26600000.00
URE.TO income_statement (annual, 2023-12-31) — Normalized Income: -29395000.00
URE.TO cash_flow (annual, 2023-12-31) — Operating Cash Flow: -16982000.00
URE.TO cash_flow (annual, 2023-12-31) — Operating Gains Losses: 1267000.00
URE.TO income_statement (annual, 2023-12-31) — Operating Income: -30842000.00
URE.TO income_statement (annual, 2023-12-31) — Operating Revenue: 17328000.00
URE.TO balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 270898900.00
URE.TO balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 5694000.00
URE.TO balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 1743000.00
URE.TO balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: 3718000.00
URE.TO income_statement (annual, 2023-12-31) — Other Gand A: 6154000.00
URE.TO income_statement (annual, 2023-12-31) — Other Income Expense: -1285000.00
URE.TO balance_sheet (annual, 2023-12-31) — Other Inventories: 2571000.00
URE.TO cash_flow (annual, 2023-12-31) — Other Non Cash Items: 11229000.00
URE.TO balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 8549000.00
URE.TO income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -24000.00
URE.TO income_statement (annual, 2023-12-31) — Other Operating Expenses: 2606000.00
URE.TO balance_sheet (annual, 2023-12-31) — Other Properties: 71308000.00
URE.TO balance_sheet (annual, 2023-12-31) — Other Receivables: 77000.00
URE.TO balance_sheet (annual, 2023-12-31) — Payables: 1788000.00
URE.TO balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 2366000.00
URE.TO balance_sheet (annual, 2023-12-31) — Prepaid Assets: 1321000.00
URE.TO income_statement (annual, 2023-12-31) — Pretax Income: -30656000.00
URE.TO cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 1517000.00
URE.TO cash_flow (annual, 2023-12-31) — Provisionand Write Offof Assets: 0.00
URE.TO cash_flow (annual, 2023-12-31) — Purchase Of PPE: -2039000.00
URE.TO balance_sheet (annual, 2023-12-31) — Receivables: 77000.00
URE.TO income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 19365000.00
URE.TO income_statement (annual, 2023-12-31) — Reconciled Depreciation: 2981000.00
URE.TO cash_flow (annual, 2023-12-31) — Repayment Of Debt: -5409000.00
URE.TO income_statement (annual, 2023-12-31) — Research And Development: 20396000.00
URE.TO balance_sheet (annual, 2023-12-31) — Retained Earnings: -250911000.00
URE.TO income_statement (annual, 2023-12-31) — Selling General And Administration: 6154000.00
URE.TO balance_sheet (annual, 2023-12-31) — Share Issued: 270898900.00
URE.TO cash_flow (annual, 2023-12-31) — Stock Based Compensation: 1026000.00
URE.TO balance_sheet (annual, 2023-12-31) — Stockholders Equity: 74870000.00
URE.TO balance_sheet (annual, 2023-12-31) — Tangible Book Value: 74870000.00
URE.TO income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
URE.TO income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
URE.TO balance_sheet (annual, 2023-12-31) — Total Assets: 128376000.00
URE.TO balance_sheet (annual, 2023-12-31) — Total Capitalization: 74870000.00
URE.TO balance_sheet (annual, 2023-12-31) — Total Debt: 6543000.00
URE.TO balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 74870000.00
URE.TO income_statement (annual, 2023-12-31) — Total Expenses: 48521000.00
URE.TO balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 53506000.00
URE.TO balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 64707000.00
URE.TO balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 43472000.00
URE.TO income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -30842000.00
URE.TO balance_sheet (annual, 2023-12-31) — Total Tax Payable: 108000.00
URE.TO income_statement (annual, 2023-12-31) — Total Unusual Items: -1261000.00
URE.TO income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -1261000.00
URE.TO balance_sheet (annual, 2023-12-31) — Work In Process: 0.00
URE.TO balance_sheet (annual, 2023-12-31) — Working Capital: 53635000.00
URE.TO income_statement (quarterly, 2024-09-30) — Basic Average Shares: 341418122.00
URE.TO income_statement (quarterly, 2024-09-30) — Basic EPS: -0.02
URE.TO income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 341418122.00
URE.TO income_statement (quarterly, 2024-09-30) — Diluted EPS: -0.02
URE.TO cash_flow (quarterly, 2024-09-30) — Net Other Financing Charges: -3877000.00
URE.TO income_statement (quarterly, 2024-09-30) — Total Other Finance Cost: -1220000.00
URE.TO income_statement (annual, 2024-12-31) — +Operating Expense: 54116000.00
URE.TO income_statement (annual, 2024-12-31) — +Total Revenue: 33706000.00
URE.TO balance_sheet (annual, 2024-12-31) — Accounts Payable: 3292000.00
URE.TO balance_sheet (annual, 2024-12-31) — Accounts Receivable: 16511000.00
URE.TO balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -25573000.00
URE.TO balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 19468000.00
URE.TO income_statement (annual, 2024-12-31) — Basic Average Shares: 317661375.00
URE.TO income_statement (annual, 2024-12-31) — Basic EPS: -0.17
URE.TO cash_flow (annual, 2024-12-31) — Beginning Cash Position: 68249000.00
URE.TO cash_flow (annual, 2024-12-31) — Capital Expenditure: -9046000.00
URE.TO balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 1240000.00
URE.TO balance_sheet (annual, 2024-12-31) — Capital Stock: 413242000.00
URE.TO balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 76055000.00
URE.TO balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 76055000.00
URE.TO balance_sheet (annual, 2024-12-31) — Cash Equivalents: 67363000.00
URE.TO balance_sheet (annual, 2024-12-31) — Cash Financial: 8692000.00
URE.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 99890000.00
URE.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -9046000.00
URE.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -71918000.00
URE.TO cash_flow (annual, 2024-12-31) — Change In Inventory: -24178000.00
URE.TO cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 2098000.00
URE.TO cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -251000.00
URE.TO cash_flow (annual, 2024-12-31) — Change In Receivables: -17707000.00
URE.TO cash_flow (annual, 2024-12-31) — Change In Working Capital: -40038000.00
URE.TO cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -16511000.00
URE.TO cash_flow (annual, 2024-12-31) — Changes In Cash: 18926000.00
URE.TO balance_sheet (annual, 2024-12-31) — Common Stock: 413242000.00
URE.TO balance_sheet (annual, 2024-12-31) — Common Stock Equity: 132799000.00
URE.TO cash_flow (annual, 2024-12-31) — Common Stock Issuance: 97568000.00
URE.TO cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 0.00
URE.TO income_statement (annual, 2024-12-31) — Cost Of Revenue: 42679000.00
URE.TO balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 816000.00
URE.TO balance_sheet (annual, 2024-12-31) — Current Assets: 115261000.00
URE.TO balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 309000.00
URE.TO balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 309000.00
URE.TO balance_sheet (annual, 2024-12-31) — Current Liabilities: 19254000.00
URE.TO balance_sheet (annual, 2024-12-31) — Current Provisions: 63000.00
URE.TO cash_flow (annual, 2024-12-31) — Depreciation: 3122000.00
URE.TO cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 3122000.00
URE.TO cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 3122000.00
URE.TO balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 2529000.00
URE.TO income_statement (annual, 2024-12-31) — Diluted Average Shares: 317661375.00
URE.TO income_statement (annual, 2024-12-31) — Diluted EPS: -0.17
URE.TO income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -53189000.00
URE.TO income_statement (annual, 2024-12-31) — EBIT: -52853000.00
URE.TO income_statement (annual, 2024-12-31) — EBITDA: -49731000.00
URE.TO cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -97000.00
URE.TO cash_flow (annual, 2024-12-31) — End Cash Position: 87078000.00
URE.TO balance_sheet (annual, 2024-12-31) — Financial Assets: 0.00
URE.TO balance_sheet (quarterly, 2024-12-31) — Financial Assets: 0.00
URE.TO cash_flow (annual, 2024-12-31) — Financing Cash Flow: 99890000.00
URE.TO cash_flow (annual, 2024-12-31) — Free Cash Flow: -80964000.00
URE.TO cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: -6444000.00
URE.TO income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 6524000.00
URE.TO balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 4189000.00
URE.TO income_statement (annual, 2024-12-31) — General And Administrative Expense: 8044000.00
URE.TO balance_sheet (annual, 2024-12-31) — Gross PPE: 92290000.00
URE.TO income_statement (annual, 2024-12-31) — Gross Profit: -8973000.00
URE.TO cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 53189000.00
URE.TO income_statement (annual, 2024-12-31) — Interest Expense: 336000.00
URE.TO income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 336000.00
URE.TO income_statement (annual, 2024-12-31) — Interest Income: 3677000.00
URE.TO income_statement (annual, 2024-12-31) — Interest Income Non Operating: 3677000.00
URE.TO cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 336000.00
URE.TO balance_sheet (annual, 2024-12-31) — Inventory: 20744000.00
URE.TO balance_sheet (annual, 2024-12-31) — Invested Capital: 132799000.00
URE.TO cash_flow (annual, 2024-12-31) — Investing Cash Flow: -9046000.00
URE.TO cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 97568000.00
URE.TO cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 0.00
URE.TO cash_flow (annual, 2024-12-31) — Issuance Of Debt: 0.00
URE.TO balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 931000.00
URE.TO balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 931000.00
URE.TO cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 0.00
URE.TO cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -5727000.00
URE.TO balance_sheet (annual, 2024-12-31) — Long Term Provisions: 36857000.00
URE.TO balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 13916000.00
URE.TO cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 97568000.00
URE.TO cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 0.00
URE.TO cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: -80000.00
URE.TO income_statement (annual, 2024-12-31) — Net Income: -53189000.00
URE.TO income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -53189000.00
URE.TO income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -53189000.00
URE.TO income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -53189000.00
URE.TO income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -53189000.00
URE.TO cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -53189000.00
URE.TO income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -53189000.00
URE.TO income_statement (annual, 2024-12-31) — Net Interest Income: 3341000.00
URE.TO cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -5336000.00
URE.TO cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -5336000.00
URE.TO income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 3341000.00
URE.TO cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -4683000.00
URE.TO cash_flow (quarterly, 2024-12-31) — Net Other Financing Charges: 0.00
URE.TO balance_sheet (annual, 2024-12-31) — Net PPE: 66717000.00
URE.TO cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -9046000.00
URE.TO balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 132799000.00
URE.TO balance_sheet (annual, 2024-12-31) — Non Current Accounts Receivable: 1127000.00
URE.TO income_statement (annual, 2024-12-31) — Normalized EBITDA: -56255000.00
URE.TO income_statement (annual, 2024-12-31) — Normalized Income: -59713000.00
URE.TO cash_flow (annual, 2024-12-31) — Operating Cash Flow: -71918000.00
URE.TO cash_flow (annual, 2024-12-31) — Operating Gains Losses: -6524000.00
URE.TO income_statement (annual, 2024-12-31) — Operating Income: -63089000.00
URE.TO income_statement (annual, 2024-12-31) — Operating Revenue: 33146000.00
URE.TO balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 364101038.00
URE.TO balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 14408000.00
URE.TO balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 14408000.00